Sign in

    Jessica PatelJefferies

    Jessica Patel is a Vice President and Equity Research Analyst at Jefferies, specializing in coverage of companies within the healthcare and biotechnology sectors. She has covered firms such as Pfizer, AbbVie, and Moderna, and is known for her in-depth analysis and strong track record, consistently delivering actionable insights and maintaining above-average success rates for her investment recommendations. Patel began her career at Morgan Stanley in 2013 before moving to Barclays, and joined Jefferies in 2019, where she quickly advanced to her current role. She holds FINRA Series 7, 63, and 86/87 licenses and has been recognized by industry platforms for both her research accuracy and client impact.

    Jessica Patel's questions to Serve Robotics Inc (SERV) leadership

    Jessica Patel's questions to Serve Robotics Inc (SERV) leadership • Q3 2024

    Question

    Jessica Patel questioned the potential impact of changing international tariffs, particularly with China, on Serve's supply chain and manufacturing costs.

    Answer

    CFO Brian Read stated that while the company monitors tariff and policy changes, its supply chain is global, with most materials sourced from countries other than China, which mitigates direct impact. He also noted the team is dialed in on regulatory and policy matters at the local level.

    Ask Fintool Equity Research AI